Table 2:

Multivariable linear regression models for factors associated with NIHSS score at 24 hours post-MT in the entire cohort, patients with LVOs, and DMVOsa

B95% CI for BβP Value
All patients
 Initial NIHSS score0.4180.315–0.5220.427<.001
 LA (grade 3–4)2.6850.716–4.6540.138.008
 HIR ≥ 0.543.2371.156–5.3190.163.002
 Use of rtPA−2.214(−3.924)–(−0.505)−0.129.011
 Pre-MT SBP0.0290.0001–0.0580.101.047
 No. of passes1.3250.731–1.9190.242<.001
 TICI score 2b–3−2.803−5.715–0.109−0.103.059
 Stroke etiology (cryptogenic)1.586−0.019–3.19010.098.053
LVOs
 Initial NIHSS score0.3730.226–0.5200.366<.001
 HIR ≥ 0.543.9681.194–6.7420.210.005
 Use of rtPA−3.802(−6.428)–(−1.176)−0.206.005
 Pre-MT SBP0.0450.003–0.0870.154.035
 No. of passes1.3040.558–2.0500.250.001
 Stroke etiology (cryptogenic)2.4300.022–4.8370.140.048
DMVOs
 LA (grade 3–4)3.2800.912–5.6480.202.007
 No. of passes1.0880.181–1.9950.181.019
 TICI score 2b–3−5.978(−9.64)–(−2.316)−0.245.002
 Stroke etiology (LAA)3.7080.184–7.2320.144.039
  • Note:—LAA indicates large artery atherosclerosis.

  • a Models are adjusted for age, sex, initial NIHSS score, ASPECTS, CTA collateral score, rCBF <38%, HIR, LA, rtPA use, pre-MT SBP, time from LKW to presentation, TICI score, number of passes during MT, and stroke etiology. We used P < .1 as a criterion for backward steps. All patients: Adjusted R2 = 0.452, F = 24.180, P <.001. LVOs group: Adjusted R2 = 0.414, F = 15.262, P <.001. DMVOs group: Adjusted R2 = 0.516, F = 22.994, P <.001.